The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
November 14th 2024
A study found a 3.5-fold increased schizophrenia risk in those with hallucinogen-related emergency department visits.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
New Schizophrenia Drug Extends Time to Relapse and Treatment Discontinuation
September 21st 2009The results of a new clinical trial of the schizophrenia drug Saphris (asenapine) has shown that the drug is effective at significantly extending both the time to relapse or impending relapse and the time to treatment discontinuation.
Depression Following a Coronary Event Increases Risk of Death
September 16th 2009Patients who suffer from depression in the first several weeks after being hospitalized for a coronary event and those patients whose depression does not improve over six months are at an increased risk of death compared to coronary patients who are not depressed.
Stress in the Workplace may Decrease an Individual's Risk for Developing Rheumatoid Arthritis
September 10th 2009Psychosocial work stress has been previously associated with an increased risk for cardiovascular disease. New research now reveals that high work stress may actually decrease an individual's chance of developing inflammatory conditions, including rheumatoid arthritis.
Majority of Chronic Pain Patients Improperly Use Prescribed Medications
August 27th 2009An Ameritox study found that of 938,586 urine toxicology tests administered to chronic pain patients over a three-year period, 11% detected major illicit drugs and 29% had a medication in their system that the patient's doctor was likely unaware of.
New Inhaled Therapy Provides Significant Relief from Migraine Pain
August 20th 2009Researchers from the Jefferson Headache Center have completed a multi-center, phase 3 clinical trial demonstrating that Levadex, an orally-inhaled migraine therapy, provides “significant relief” from migraine symptoms.
Bonus or Bogus? Are federal funds for health IT a true stimulus, or merely a stopgap?
What do physicians really think about the HITECH act, health IT stimulus incentives, and the government’s new role in their lives? Using the power of social media, we did a little research and asked MDNG readers to share their opinions, concerns, and advice.
Mapping the Brain to Detect Early Mental Disorders
July 31st 2009Researcher John Csernansky, MD, is working to produce a "map of the unique dips, swells and crevasses of the brains of individuals that he hopes will provide the first scientific tool for early and more definite diagnosis of mental disorders such as schizophrenia."